Lijing Chen from Pasadena, CA, age 49

view source

Location:

85 Twyla Pl, Buffalo, NY 14223

Industry:

Research

Work:

Roche
Research Associate Iii at Roche

Education:

State University of New York at Buffalo - School of Pharmacy and Pharmaceutical Sciences 1999 - 2001
Master of Science, Masters

Name / Title

Company / Classification

Phones & Addresses

Lijing Chen
Administrator

Four Seasons Rl Est & Mgmt Inc
Plastics, Foil, and Coated Paper Bags

4232 College Point Blvd, Flushing, NY 11355

Lijing Chen
Chairman

Fa Mings Construction Corp
Single-Family House Construction

4240 161 St, Flushing, NY 11358

Heterocyclic Inhibitors Of Glutaminase
view source
US Patent:

8604016, Dec 10, 2013
Filed:

Nov 19, 2012
Appl. No.:

13/680582
Inventors:

Lijing Chen - Cupertino CA, US
Bindu Goyal - Fremont CA, US
Guy Laidig - Woodside CA, US
Timothy Friend Stanton - Daly City CA, US
Eric Brian Sjogren - Mountain View CA, US
Assignee:

Calithera Biosciences Inc. - South San Francisco CA
International Classification:

C07D 285/135
C07D 417/06
C07D 417/14
US Classification:

51421018, 5142365, 51425202, 51425203, 51425205, 514314, 514333, 514363, 544114, 544238, 546174, 546256, 548139
Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

Anilino-Pyrimidine Analogs
view source
US Patent:

20060079543, Apr 13, 2006
Filed:

Oct 13, 2005
Appl. No.:

11/248495
Inventors:

Fuk-Wah Sum - Pomona NY, US
Dennis Powell - Cortlandt Manor NY, US
Yixian Zhang - Pearl River NY, US
Lijing Chen - Cupertino CA, US
Scott Kincaid - Middletown NY, US
Lee Jennings - Chestnut Ridge NY, US
Yongbo Hu - River Edge NJ, US
Adam Gilbert - Congers NY, US
Matthew Bursavich - Tuckahoe NY, US
Assignee:

Wyeth - Madison NJ
International Classification:

A61K 31/506
C07D 417/02
C07D 403/02
US Classification:

514275000, 544329000, 544330000
Abstract:

The present invention relates to compounds of formula I: wherein R, R, R, R, R, and Rare defined herein.

Heterocyclic Inhibitors Of Glutaminase
view source
US Patent:

20140050699, Feb 20, 2014
Filed:

Oct 10, 2013
Appl. No.:

14/051216
Inventors:

Lijing Chen - Cupertino CA, US
Bindu Goyal - Fremont CA, US
Guy Laidig - Woodside CA, US
Timothy Friend Stanton - Daly City CA, US
Eric Brian Sjogren - Mountain View CA, US
Assignee:

CALITHERA BIOSCIENCES INC. - South San Francisco CA
International Classification:

C07D 417/06
C07D 417/14
A61K 31/5377
A61B 18/02
A61K 45/06
A61N 5/00
A61N 7/00
A61K 31/501
A61K 31/506
US Classification:

424 854, 51425205, 5142362, 51425203, 51425202, 51421018, 4241331, 514 34, 424 946, 514 209, 424649, 514171, 600 1, 601 2, 606 20
Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

Ectonucleotidase Inhibitors And Methods Of Use Thereof
view source
US Patent:

20230022922, Jan 26, 2023
Filed:

Jun 28, 2021
Appl. No.:

17/359990
Inventors:

Lijing Chen - Cupertino CA, US
Roland Joseph Billedeau - Santa Clara CA, US
Jim Li - San Francisco CA, US
International Classification:

C07H 19/167
C07H 19/067
C07H 19/23
Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.

Ectonucleotidase Inhibitors And Methods Of Use Thereof
view source
US Patent:

20230002437, Jan 5, 2023
Filed:

May 13, 2021
Appl. No.:

17/319224
Inventors:

- South San Francisco CA, US
Jim Li - San Francisco CA, US
Lijing Chen - Cupertino CA, US
International Classification:

C07H 19/167
A61P 35/00
A61P 25/16
A61P 37/00
A61P 25/24
A61P 29/00
Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.

Heterocyclic Glutaminase Inhibitors
view source
US Patent:

20210292289, Sep 23, 2021
Filed:

Oct 5, 2020
Appl. No.:

17/063066
Inventors:

- South San Francisco CA, US
Lijing Chen - Cupertino CA, US
Bindu Goyal - Fremont CA, US
Guy Laidig - Woodside CA, US
Timothy F. Stanton - Pacifica CA, US
Eric B. Sjogren - Mountain View CA, US
International Classification:

C07D 285/135
C07D 417/06
A61K 31/501
A61K 31/422
A61K 31/4155
A61K 31/427
C07D 417/14
Abstract:

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

Compositions And Methods For Inhibiting Arginase Activity
view source
US Patent:

20210261573, Aug 26, 2021
Filed:

Jan 20, 2021
Appl. No.:

17/153804
Inventors:

- South San Francisco CA, US
Jim LI - San Francisco CA, US
Lijing CHEN - Cupertino CA, US
Roland J. BILLEDEAU - Santa Clara CA, US
Timothy F. STANTON - Daly City CA, US
Michael VAN ZANDT - Guilford CT, US
Darren WHITEHOUSE - Westbrook CT, US
Lene Raunkjaer PETERSEN - Vaerlose, DK
Assignee:

CALITHERA BIOSCIENCES, INC. - South San Francisco CA
International Classification:

C07F 5/02
A61K 31/69
A61P 35/00
A61K 45/06
A61K 39/395
C07K 16/28
A61P 35/02
A61K 31/4245
Abstract:

The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.

Compositions And Methods For Inhibiting Arginase Activity
view source
US Patent:

20200339607, Oct 29, 2020
Filed:

Feb 14, 2020
Appl. No.:

16/792186
Inventors:

- South San Francisco CA, US
Jim LI - San Francisco CA, US
Lijing CHEN - Cupertino CA, US
Roland J. BILLEDEAU - Santa Clara CA, US
Timothy F. STANTON - Daly City CA, US
Michael VAN ZANDT - Guilford CT, US
Darren WHITEHOUSE - Westbrook CT, US
Gunnar E. JAGDMANN - Branford CT, US
Lene Raunkjær PETERSEN - Værløse, DK
Assignee:

CALITHERA BIOSCIENCES, INC. - South San Francisco CA
International Classification:

C07F 5/02
A61K 31/69
A61P 35/00
A61K 45/06
A61K 39/395
C07K 16/28
A61P 35/02
A61K 31/4245
Abstract:

The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.